However, the systematic review and meta-analysis confirmed CEA's prognostic role in patients with appendiceal or colorectal adenocarcinoma.<h4>Conclusion</h4>The absence of DNA mutations suggests that metastatic potential may be driven by downstream mRNA or protein modifications in the CEA PELPK region. The gene discussed is CEACAM5; the disease is colorectal adenocarcinoma.